Vira Shield 4

Manufacturer: Novartis (Farm Animal)

Bovine Rhinotracheitis-virus Diarrhea Vaccine

Killed Virus

For Use In Animals Only

Vira Shield 4 Indications

For use in healthy cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR) and bovine virus diarrhea (BVD Type 1 and BVD Type 2) viruses. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates.

Adjuvant

Xtend^® SP.

Directions

Shake well before using. Administer 5 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 4-5 weeks. Vaccinate dairy cows at dry-off. Revaccinate annually or as recommended by your veterinarian.

Precautions

Store out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2011 Novartis; Registered trademarks of Novartis AG

50 Doses

250 mL

144-02

Nac No.

11141120